Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 680 across all filing types
Latest filing 2021-03-12 Regulatory Filings
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 12, 2021, addressed to stock exchanges in India, informing about the schedule of an upcoming analyst/institutional investor meeting (Motilal Oswal - 60 Minutes With The Management) on March 17, 2021. It is an announcement of a planned investor conference call or meeting, not the transcript or detailed presentation itself. The document length is only 1541 characters, indicating it is a brief notice rather than a full report or transcript. There is no financial data, no detailed discussion of results, no voting results, no audit information, or other report content. This fits the category of an Investor Presentation announcement or schedule notice. However, since it only announces the schedule of the meeting and does not contain the presentation itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about an upcoming event. The document does not meet the criteria for a full Call Transcript (CT) or Investor Presentation (IP).
2021-03-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 5, 2021, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, results, or detailed presentations. The document is essentially an announcement of upcoming investor meetings, not a full investor presentation or financial report. Given its brevity (1525 characters) and content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2021-03-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 25, 2021, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which governs disclosure of material events. The content is an announcement of planned investor conferences and calls, not a financial report or detailed presentation. The document length is only 1600 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no detailed analysis, or results disclosed. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings and does not fit into other specific categories like Investor Presentation or Earnings Release.
2021-02-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 23, 2021, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content is an announcement of upcoming investor meetings, not a financial report, earnings release, or detailed presentation. The document length is only 1536 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2021-02-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a notification to stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which governs disclosures related to investor relations activities. The content is a schedule of upcoming meetings rather than a financial report, earnings release, or any detailed presentation. It is an announcement of meetings with investors and analysts, which fits the category of Investor Presentation announcements or updates. However, since it is only a schedule notice and not the presentation itself, it aligns best with the category for Investor Presentation (IP) as it relates to investor communications and meetings.
2021-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 15, 2021, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, results, or detailed report content. The document is essentially an announcement of upcoming investor meetings, not a financial report or earnings release. Given its brief nature (1541 characters) and content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2021-02-15 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.